De Groot N, Van Kuik-Romeijn P, Lee S H, De Boer H A
Medical Biotechnology Department, Leiden University, 2300 RA Leiden, the Netherlands.
Immunology. 2000 Oct;101(2):218-24. doi: 10.1046/j.1365-2567.2000.00094.x.
The polymeric immunoglobulin receptor (pIgR) transports dimeric immunoglobulin A (dIgA) across the epithelial cell layers into the secretions of various mucosal and glandular surfaces of mammals. At these mucosal sites, such as the gastrointestinal tract, respiratory tract, urogenital tract and the mammary glands, dIgA protects the body against pathogens. The pIgR binds dIgA at the basolateral side and transports it via the complex mechanism of transcytosis to the apical side of the epithelial cells lining the mucosa. Here, the extracellular part of the receptor is cleaved to form the secretory component (SC), which remains associated to dIgA, thereby protecting it from degradation in the secretions. One pIgR molecule transports only one dIgA molecule (1 : 1 ratio) and the pIgR is not recycled after each round of transport. This implies that the amount of available receptor could be a rate-limiting factor determining both the rate and amount of IgA transported per cell and therefore determining the total IgA output into the lumen or, in case of the mammary gland, into the milk. In order to test this hypothesis, we set up an in vivo model system. We generated transgenic mice over-expressing the murine pIgR gene under lactogenic control, by using a milk gene promoter, rather than under immunological control. Mice over-expressing the pIgR protein, in mammary gland epithelial cells, from 60- up to 270-fold above normal pIgR protein levels showed total IgA levels in the milk to be 1.5-2-fold higher, respectively, compared with the IgA levels in the milk of non-transgenic mice. This indicates that the amount of pIgR produced is indeed a limiting factor in the transport of dIgA into the milk under normal non-inflammatory circumstances.
聚合免疫球蛋白受体(pIgR)将二聚体免疫球蛋白A(dIgA)转运穿过上皮细胞层,进入哺乳动物各种黏膜和腺体表 面的分泌物中。在这些黏膜部位,如胃肠道、呼吸道、泌尿生殖道和乳腺,dIgA保护机体抵御病原体。pIgR在基底外侧结合dIgA,并通过转胞吞作用的复杂机制将其转运至黏膜内衬上皮细胞的顶端侧。在此处,受体的细胞外部分被裂解形成分泌成分(SC),SC仍与dIgA结合,从而保护其在分泌物中不被降解。一个pIgR分子仅转运一个dIgA分子(1:1比例),且每一轮转运后pIgR不会再循环利用。这意味着可用受体的数量可能是一个限速因素,它既决定了每个细胞转运IgA的速率和数量,也因此决定了进入管腔的总IgA输出量,或者在乳腺的情况下,决定了进入乳汁的总IgA输出量。为了验证这一假设,我们建立了一个体内模型系统。我们通过使用乳基因启动子而非免疫控制,构建了在泌乳控制下过表达鼠pIgR基因的转基因小鼠。在乳腺上皮细胞中过表达pIgR蛋白的小鼠,其pIgR蛋白水平比正常水平高60至270倍,与非转基因小鼠乳汁中的IgA水平相比,其乳汁中的总IgA水平分别高出1.5至2倍。这表明在正常非炎症情况下,pIgR的产生量确实是dIgA转运至乳汁过程中的一个限制因素。